Navigation Links
Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists
Date:1/9/2012

By parsing apart the chemical interactions at the microbe-human interface, he will better understand how to minimize microbes capable of causing cancer while maximizing protective ones.

Dr. Crawford will soon be moving to an Assistant Professor faculty position at Yale University, New Haven, Connecticut.

November 2011 Damon Runyon Fellows:

Mary J. Carroll, PhD, with her sponsor Stephen W. Fesik, PhD, at Vanderbilt University Medical Center, Nashville, Tennessee, aims to design small molecule inhibitor drugs with high affinity for the protein Vav1. This protein is an attractive target for treating pancreatic cancer because it is highly expressed in pancreatic adenocarcinomas and activates pro-cancer signaling.

Sidi Chen, PhD, with his sponsor Phillip A. Sharp, PhD, at Massachusetts Institute of Technology, Cambridge, Massachusetts, aims to understand the relationship between small RNAs and cancer. Small RNAs are important regulators of genetic networks inside the cell; perturbation of these networks can lead to malignant cell growth. His goal is to develop anti-cancer drugs and therapies by targeting the process of small RNA production.

Stephanie T. Chen, PhD, with her sponsor David J. Julius, PhD, at University of California, San Francisco, California, is studying somatosensation, the sense of "touch," with a focus on pain sensation. She aims to identify novel proteins that a) drive the development of sensory neurons, and b) confer the ability to detect painful stimuli under normal and pathophysiological conditions, including those leading to cancer-induced pain.

Jason A. Hall, PhD, with his sponsor Dan R. Littman, MD, PhD, at New York University School of Medicine, New York, New York, is investigating the biochemical and metabolic pathways that regulate the activity of the protein ROR gamma t, which has crucial importance in metabolism and immune system homeostasis. It is also linked to the developm
'/>"/>

Contact: Yung S. Lie, PhD
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award
2. 2009 Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
3. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators
4. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 11 top young scientists
5. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
6. Damon Runyon Cancer Research Foundation awards breakthrough scientists
7. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
8. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
9. Exciting new companies at NJITs small biz incubator get 100K in grants
10. National Science Foundation grants Clemson professors award to develop nanoprobes
11. Dunn Foundation gives Rice $3M for collaborative research grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Chine, 31 juillet 2015 La 10e ... ) sera organisée par le BGI du 22 ... en Chine. La conférence ... inauguration en 2006, l,ICG est devenue l,une des ... domaine des « omiques » et c,est aussi la plus ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, ... for gene function analysis and biomarker discovery, announced ... (sgRNA) Knockout Library targeting all human protein coding ... permanently "knock out" a gene,s function. Cellecta,s new ... high throughput screening tool so that researchers can ...
(Date:7/21/2015)... -- Today, ZTE announced its Android smartphone Axon, featuring ... revenues in 2015 that relate to sales of FPC1025 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... China and we are proud that ... Axon , its first ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... preference for speech through in-utero eavesdropping, or is their ... test, but one that's central to understanding the origins ... a McGill University psychologist believes she's separated out the ... results, says Dr. Athena Vouloumanos, point to a genetic ...
... University of Pennsylvania School of Medicine discovered that a ... internal molecular clock in mammals. What's more, this molecule ... light on circadian rhythm disorders, including bipolar disorder. The ... metabolism, are reported in this week's issue of Science. ...
... Scientists supported by the National Institute of Allergy and ... Health (NIH), have identified a defect in the immune ... that puts them at risk of developing serious complications ... Ph.D., of the National Jewish Medical and Research Center ...
Cached Biology News:Born with a love of speech 2Born with a love of speech 3Clock molecule's sensitivity to lithium sheds light on bipolar disorder 2Defective immune system response to smallpox vaccine detailed in new study 2Defective immune system response to smallpox vaccine detailed in new study 3
(Date:7/30/2015)... 2015 AACC welcomed thousands of medical ... Annual Meeting & Clinical Lab Expo in ... meeting showcased revolutionary advancements in clinical testing technology ... providers to diagnose patients quickly and accurately and ... As of Wednesday, July 29, more ...
(Date:7/30/2015)... Texas (PRWEB) , ... July 30, 2015 , ... The ... and in-depth study on the current state of the global Propanol market with a ... Sinopec, CNPC, BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch ...
(Date:7/30/2015)... 2015   Aratana Therapeutics, Inc . (NASDAQ: ... on the licensing, development and commercialization of innovative ... its strategic partner VetStem Biopharma, Inc. has shared ... AT-016, an adipose-derived allogeneic stem cell product exclusively ... pain in dogs. The double-blinded, multi-site, ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... discovery that low-intensity, pulsed ultrasound can be used ... for engineering rapid-response medical devices. The team that ... an assistant professor with the Virginia Tech Carilion ... detailing this approach, which may one day lead ...
... Sept. 8, 2011 Enterologics, Inc  ( ... acquisition of The BioBalance Corporation and its subsidiary BioBalance ... this purchase Enterologics acquired its first probiotic biotherapeutic product, ... coli M17 has an active Investigational New Drug ...
... Seeds, an investment firm dedicated to achieving above market ... announced today that it has opened an office at ... support the growing number of investments the firm has ... its first Pittsburgh investment in 2006 in Redpath Pathologies, ...
Cached Biology Technology:Neuroscientists produce guide for ultrasound use to treat brain disorders in clinical emergencies 2Neuroscientists produce guide for ultrasound use to treat brain disorders in clinical emergencies 3Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc 2Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc 3Enterologics Completes Acquisition of BioBalance Corp and Probiotic Product From New York Health Care, Inc 4Golden Seeds Opens Office in PLSG Incubator 2Golden Seeds Opens Office in PLSG Incubator 3
... The H2OBIT™ is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
... licensed, high throughput, water bath thermal cycler capable ... microplates. This equates to 9,216 reactions per run ... rapidly transfers a basket of plates between three ... are considerably faster than those of peltier block ...
... is a 27kDa periplasmic enzyme from E. ... to cyclic nucleotide monophosphate (NMP) intermediates. Slower ... intermediates to 3-NMPs (1). RNase ONE Ribonuclease ... that can cleave a phosophodiester bond between ...
... Dideoxycytidine is a cytidine analog that has been ... Immunogen: Chemical / Small Molecule ... specificity of the ddC antiserum was determined by ... to moles of ddC analog at the 50% ...
Biology Products: